首页> 外国专利> DIPEPTIDE-BASED NEAR-INFRARED IMAGING PROBE FOR TARGETING HEPSIN, AND COMPOSITION FOR NEAR-INFRARED IMAGING FOR METASTATIC CANCER DIAGNOSIS, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING METASTATIC CANCER, BOTH COMPOSITIONS COMPRISING PROBE

DIPEPTIDE-BASED NEAR-INFRARED IMAGING PROBE FOR TARGETING HEPSIN, AND COMPOSITION FOR NEAR-INFRARED IMAGING FOR METASTATIC CANCER DIAGNOSIS, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING METASTATIC CANCER, BOTH COMPOSITIONS COMPRISING PROBE

机译:基于双肽的近红外成像探针,用于靶向庚素,近红外成像的成分,用于转移性癌症的诊断,以及用于预防和治疗转移性癌症的药物成分,两者均包含探针

摘要

The present invention relates to: a near-infrared imaging probe compound for targeting hepsin which is overexpressed in metastatic cancer; and a composition for near-infrared imaging for metastatic cancer diagnosis, and a pharmaceutical composition for preventing and treating metastatic cancer, both compositions comprising the probe. The compound according to the present invention is a fluorescent imaging probe comprising a fluorescent substance such as a BODIPY derivative and Sulfo-Cyanine7 and targeting hepsin, and has excellent heptin inhibitory activity and is confirmed, by cell uptake results, to selectively bind to cells in which hepsin is expressed, thereby enabling the diagnosis, prevention and treatment of carcinoma, such as prostate cancer, in which hepsin is overexpressed at an early stage, and being variously usable in the development of hepsin inhibitors for diagnosing prostate cancer.
机译:本发明涉及在转移癌中过表达的靶向肝素的近红外成像探针化合物。以及用于转移癌诊断的近红外成像组合物以及用于预防和治疗转移癌的药物组合物,两者均包含探针​​。根据本发明的化合物是一种荧光成像探针,其包含诸如BODIPY衍生物和Sulfo-Cyanine7之类的荧光物质并靶向肝素,并且具有优异的肝素抑制活性,并且通过细胞摄取结果证实其选择性结合于肝癌细胞。肝素被表达,从而能够诊断,预防和治疗在早期阶段肝素过度表达的癌症,例如前列腺癌,并且在开发用于诊断前列腺癌的肝素抑制剂中有各种用途。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号